Rankings
▼
Calendar
PRTA Q3 2017 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena
PRTA
Prothena Corporation plc
$512M
Q3 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$219,000
-23.4% YoY
Gross Profit
-$41M
-18765.3% margin
Operating Income
-$54M
-24444.7% margin
Net Income
-$52M
-23924.2% margin
EPS (Diluted)
$-1.37
QoQ Revenue Growth
-99.2%
Cash Flow
Operating Cash Flow
-$18M
Free Cash Flow
-$18M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$538M
Total Liabilities
$91M
Stockholders' Equity
$446M
Cash & Equivalents
$456M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$219,000
$286,000
-23.4%
Gross Profit
-$41M
-$27M
-54.8%
Operating Income
-$54M
-$43M
-25.4%
Net Income
-$52M
-$43M
-21.2%
← FY 2017
All Quarters
Q4 2017 →